Financials Manhattan Scientifics, Inc.

Equities

MHTX

US5631221000

Entertainment Production

Market Closed - OTC Markets 20:13:52 17/05/2024 BST 5-day change 1st Jan Change
0.0014 USD +27.27% Intraday chart for Manhattan Scientifics, Inc. +40.00% -46.15%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4.11 5.857 23.79 8.948 4.474 1.454
Enterprise Value (EV) 1 4.023 5.674 23.54 8.846 4.409 1.447
P/E ratio -0.39 x -4.72 x 5.52 x -1.6 x -1.64 x -1.25 x
Yield - - - - - -
Capitalization / Revenue - 60,378,361 x 475,787,240 x 178,969,940 x 89,484,960 x -
EV / Revenue - 58,491,763 x 470,807,240 x 176,929,940 x 88,184,960 x -
EV / EBITDA -4.87 x -5.55 x -35 x -12.9 x -6.52 x -2.06 x
EV / FCF -25.1 x -24.7 x -16 x -43.9 x 20.7 x 19.7 x
FCF Yield -3.98% -4.05% -6.25% -2.28% 4.84% 5.09%
Price to Book -27.4 x -5.83 x 5.1 x 8.65 x -2.64 x -0.51 x
Nbr of stocks (in thousands) 533,781 557,781 557,781 559,281 559,281 559,281
Reference price 2 0.007700 0.0105 0.0426 0.0160 0.008000 0.002600
Announcement Date 01/04/19 14/04/20 15/04/21 06/04/22 13/04/23 02/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 0.097 0.05 0.05 0.05 -
EBITDA 1 -0.826 -1.023 -0.673 -0.685 -0.676 -0.702
EBIT 1 -1.448 -1.025 -0.675 -0.687 -0.679 -0.703
Operating Margin - -1,056.7% -1,350% -1,374% -1,358% -
Earnings before Tax (EBT) 1 -8.334 -1.222 4.314 -3.639 -2.73 -1.165
Net income 1 -8.334 -1.222 4.314 -3.639 -2.73 -1.165
Net margin - -1,259.79% 8,628% -7,278% -5,460% -
EPS 2 -0.0200 -0.002224 0.007726 -0.0100 -0.004881 -0.002083
Free Cash Flow 1 -0.16 -0.2298 -1.47 -0.2016 0.2135 0.0736
FCF margin - -236.86% -2,941% -403.25% 427% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 01/04/19 14/04/20 15/04/21 06/04/22 13/04/23 02/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.09 0.18 0.25 0.1 0.07 0.01
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.16 -0.23 -1.47 -0.2 0.21 0.07
ROE (net income / shareholders' equity) -165% -254% 149% -93% -375% 95.5%
ROA (Net income/ Total Assets) -13.4% -26.2% -9.3% -8.34% -18.9% -65.2%
Assets 1 62.19 4.659 -46.39 43.66 14.43 1.786
Book Value Per Share 2 -0 -0 0.0100 0 -0 -0.0100
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - 0 - - -
Capex / Sales - - 8% - - -
Announcement Date 01/04/19 14/04/20 15/04/21 06/04/22 13/04/23 02/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. MHTX Stock
  4. Financials Manhattan Scientifics, Inc.